Effect of risperidone on proliferation and apoptosis of MC3T3-E1 cells

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Lei ZhengYiming Wang

Abstract

This aim of this study was to assess the molecular mechanism of osteoporosis in schizophrenia patients with risperidone use. Here, we investigated the effects of risperidone on cellular proliferation and apoptosis of a preosteoblast cell line, MC3T3-E1. Cell viability and apoptotic rate of MC3T3-E1 were detected by cell counting kit-8 and flow cytometry at a serial dose of risperidone and at different time points, respectively. Bone transformation relevant gene serum osteocalcin (BGP), collagen 1, tumor necrosis factor-α (TNF-α), osteoprotegerin (OPG), and receptor activator of nuclear factor-κB ligand (RANKL) mRNA levels were determined by real-time PCR (qPCR). Their protein expression patterns were evaluated using western blot. The results revealed that risperidone dramatically inhibited MC3T3-E1 cell proliferation in a dose-dependent manner. It also significantly induced MC3T3-E1 cell apoptosis. TNF-α gene and protein levels were greatly enhanced after risperidone treatment. In contrast, BGP, collagen 1, OPG, and RANKL gene and protein levels were markedly downregulated. Our study indicated that risperidone suppressed MC3T3-E1 cell proliferation and induced apoptosis. It also regulated BGP gene and protein expression.

References

May 28, 1981·The New England Journal of Medicine·E KollinI Holló
May 8, 1997·Biochemical and Biophysical Research Communications·E TsudaK Higashio
Jun 4, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R L JilkaS C Manolagas
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·C RoggiaR Pacifici
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·A M MeaneyV O'Keane
Feb 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Louise HowardMorven Leese
Aug 19, 2007·Cell·Na Kyung LeeGerard Karsenty
Aug 20, 2008·Biological Reviews of the Cambridge Philosophical Society·Harry C BlairLi Sun
Jan 3, 2009·BMC Musculoskeletal Disorders·Jenn-Huei RennPesus Chou
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mone ZaidiHarry C Blair
Apr 29, 2010·Current Osteoporosis Reports·Kristy M NicksDana Gaddy
Aug 17, 2010·Regulatory Toxicology and Pharmacology : RTP·Takeshi KunimatsuTakaki Seki
Mar 10, 2011·Expert Opinion on Drug Safety·Simon Matthew GrahamEvangelia Tsapakis
Mar 30, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Reiko HanadaJosef M Penninger
Aug 29, 2013·Immunopharmacology and Immunotoxicology·Mao-Liang ChenFu-Ming Tsai
Jun 1, 2012·Therapeutic Advances in Psychopharmacology·Jeffrey R BishopJohn A Sweeney
Jun 5, 2014·Autism Research : Official Journal of the International Society for Autism Research·Dionisio A AmodeoMichael E Ragozzino
Dec 11, 2014·Journal of Cellular Biochemistry·Ian R ReidMark J Bolland
Feb 11, 2015·General Hospital Psychiatry·Brendon StubbsDavy Vancampfort
Jan 19, 2016·Lancet·Michael J OwenPreben B Mortensen
Jul 20, 2016·Molecular Medicine Reports·Fei XuShilong Huang

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
protein assay

Software Mentioned

GraphPad Prism
SPSS22

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2022 Meta ULC. All rights reserved